Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001601830-24-000102
Filing Date
2024-07-12
Accepted
2024-07-12 18:52:28
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1720824741.html 4/A  
1 FORM 4/A wk-form4a_1720824741.xml 4/A 6159
  Complete submission text file 0001601830-24-000102.txt   7763
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Gibson Christopher (Reporting) CIK: 0001856369 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40323 | Film No.: 241115468